|
1
|
|
$78.9M
|
+$1.27M
|
+72,931
|
+2%
|
|
|
2
|
Fidelity Investments
Boston,
Massachusetts
|
$68.5M
|
-$9.55M
|
-546,599
|
-13%
|
|
|
3
|
Point72 Asset Management
Stamford,
Connecticut
|
$58.7M
|
+$22.4M
|
+1,284,780
|
+65%
|
|
|
4
|
State Street
Boston,
Massachusetts
|
$50.8M
|
+$11.5M
|
+655,732
|
+30%
|
|
|
5
|
Nantahala Capital Management
New Canaan,
Connecticut
|
$50.8M
|
+$7.83M
|
+448,146
|
+19%
|
|
|
6
|
|
$24.8M
|
+$2.31M
|
+132,418
|
+11%
|
|
|
7
|
683 Capital Management
New York
|
$24.5M
|
+$1.78M
|
+101,800
|
+8%
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$21.9M
|
+$525K
|
+30,053
|
+3%
|
|
|
9
|
|
$16.6M
|
+$5.83M
|
+333,675
|
+57%
|
|
|
10
|
Aquilo Capital Management
San Francisco,
California
|
$16.3M
|
+$3.93M
|
+225,284
|
+33%
|
|
|
11
|
|
$16M
|
+$3.04M
|
+174,069
|
+24%
|
|
|
12
|
Macquarie Group
Sydney, NSW 2000,
Australia
|
$12.8M
|
–
|
–
|
–
|
|
|
13
|
Adage Capital Partners
Boston,
Massachusetts
|
$12.6M
|
+$1.75M
|
+100,000
|
+17%
|
|
|
14
|
Bank of New York Mellon
New York
|
$12.2M
|
-$602K
|
-34,476
|
-5%
|
|
|
15
|
International Biotechnology Trust
London,
United Kingdom
|
$11.8M
|
–
|
–
|
–
|
|
|
16
|
Federated Hermes
Pittsburgh,
Pennsylvania
|
$10.7M
|
-$14.8M
|
-848,042
|
-59%
|
|
|
17
|
PFM Health Sciences
San Francisco,
California
|
$9.66M
|
+$9.34M
|
+534,624
|
New
|
|
|
18
|
Tekla Capital Management
Boston,
Massachusetts
|
$9.43M
|
–
|
–
|
–
|
|
|
19
|
Privium Fund Management
Amsterdam,
Netherlands
|
$8.91M
|
+$405K
|
+23,196
|
+5%
|
|
|
20
|
Ameriprise
Minneapolis,
Minnesota
|
$8.81M
|
+$5.79M
|
+331,509
|
+212%
|
|
|
21
|
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$8.11M
|
+$7.84M
|
+448,985
|
New
|
|
|
22
|
|
$7.46M
|
-$34.3M
|
-1,961,253
|
-83%
|
|
|
23
|
|
$6.48M
|
-$915K
|
-52,396
|
-13%
|
|
|
24
|
Geode Capital Management
Boston,
Massachusetts
|
$6.45M
|
-$122K
|
-7,004
|
-2%
|
|
|
25
|
Hudson Bay Capital Management
Stamford,
Connecticut
|
$6.05M
|
+$786K
|
+45,000
|
+16%
|
|
